Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-16-106380
Filing Date
2016-03-18
Accepted
2016-03-18 17:07:35
Documents
1
Period of Report
2016-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a16-6760_18ka.htm 8-K/A 28060
  Complete submission text file 0001104659-16-106380.txt   29465
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35268 | Film No.: 161516820
SIC: 2834 Pharmaceutical Preparations